the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy

Save

Report Abuse

Description

This study intends to apply prospective, open, single-center, randomized controlled study to evaluate the cognitive status of patients with Idiopathic membranous nephropathy and the influence of different treatment schemes on the cognitive status of patients with Idiopathic membranous nephropathy, and explore the possible pathophysiological mechanism by using brain magnetic resonance imaging technology.

Study Overview

Start Date
October 1, 2023
Completion Date
September 30, 2025
Enrollment
2
Date Posted
February 7, 2024
Accepts Healthy Volunteers?
No
Gender
All

Locations

Full Address
Beijing Friedship Hospital
Beijing, Beijing 100050, China

Eligibility

Minimum Age (years)
18
Maximum Age (years)
70
Eligibility Criteria
Inclusion Criteria:

Patients with nephrotic syndrome and normal renal function.
Patients with idiopathic membranous nephropathy diagnosed by pathology.
not received hormone or other immunosuppressive treatment in the past six months.

Exclusion Criteria:

Unable to treat patients with hormones and immunosuppression.
Patients with definite intracranial diseases such as previous cerebral infarction and cerebral hemorrhage;
Patients who have been diagnosed with cognitive decline or dementia in the past;
Patients with claustrophobia or have other contraindications for magnetic resonance imaging, such as pacemakers and metal foreign bodies in the body.
Pregnant and lactating women

Study Contact Info

Study Contact Name
Wenhu Liu
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
Detailed Description
Proteinuia is an independent risk factor for cognitive dysfunction and dementia. There is no relevant research on whether patients with Idiopathic membranous nephropathy with normal renal function are complicated with cognitive impairment. In the process of clinical diagnosis and treatment, it was observed that the cognitive function of patients with Idiopathic membranous nephropathy decreased significantly after treatment compared with that before treatment. However, there is no clinical study to confirm this phenomenon at present, and the causes of cognitive function damage are not clear. This study intends to apply prospective, open, single-center, randomized controlled study to evaluate the cognitive status of patients with Idiopathic membranous nephropathy and the influence of different treatment schemes on the cognitive status of patients with Idiopathic membranous nephropathy, and explore the possible pathophysiological mechanism by using brain magnetic resonance imaging technology, so as to fill the research gap of clinical cognitive status of Idiopathic membranous nephropathy and provide theoretical basis for better clinical treatment scheme selection and prevention of cognitive impairment.
NCTid (if applicable)
NCT06245707